Loading…
Cytotoxic evaluation of Dovyalis Caffra leaf extract-mediated hematite-(Fe2O3) nanoparticles for biological applications
Although hematite (Fe 2 O 3 ) nanoparticles are gaining attention for biomedical purposes due to their unique properties, eco-friendly synthesis using plant extracts is being explored due to toxicity concerns of the resulting material. This study explores the use of plant extracts ( Dovyalis caffra...
Saved in:
Published in: | Nano express 2024-09, Vol.5 (3), p.35004 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Although hematite (Fe 2 O 3 ) nanoparticles are gaining attention for biomedical purposes due to their unique properties, eco-friendly synthesis using plant extracts is being explored due to toxicity concerns of the resulting material. This study explores the use of plant extracts ( Dovyalis caffra leaf extracts) for the synthesis of Fe 2 O 3 nanoparticles alongside their cytotoxicity profile using human embryonic kidney cells (HEK293) and human cervical cancer cells (HeLa). The physicochemical properties of the prepared nanoparticles were established using x-ray diffraction (XRD) and microscopy techniques, confirming their crystalline nature and spherical morphology with minimal agglomeration. Using the MTT assay approach, the cytotoxicity profile of the nanoparticles revealed dose-dependent cytotoxic effects, with higher specificity towards cancer cells and very low toxicity towards the human cell line, suggesting safe usage as biomedical agents. While the standard drug 5-Fluorouracil possessed significantly higher cytotoxicity, its unwanted high toxicity towards normal human cells makes the Fe 2 O 3 nanoparticles a better choice. These findings suggest the potential of Dovyalis caffra leaf extract-mediated Fe 2 O 3 nanoparticles for biomedical applications, emphasizing their low toxicity towards normal human cells and specificity towards cancer cells. |
---|---|
ISSN: | 2632-959X 2632-959X |
DOI: | 10.1088/2632-959X/ad5d80 |